Cvs Health (CVS) Gains from Investment Securities (2009 - 2026)

Cvs Health has reported Gains from Investment Securities for 14 years, with the latest figure at -$337.0 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 1673.68% year-over-year to -$337.0 million; the trailing twelve-month figure through Mar 2026 stood at $18.0 million (down 86.67% YoY), and the FY2025 full-year result was $336.0 million, up 81.62% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at -$337.0 million, down from $345.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $1.8 billion in Q2 2022, with the low at -$1.8 billion in Q3 2023.
• Historically, Gains from Investment Securities has averaged $17.1 million across 5 years, with a median of $31.0 million in 2024.
• Annual changes were most pronounced in 2025 — Gains from Investment Securities jumped 8525.0% — and 2026, when it slumped 1673.68%.
• Cvs Health's Gains from Investment Securities stood at $33.0 million in 2022, then sank by 769.7% to -$221.0 million in 2023, then jumped by 101.81% to $4.0 million in 2024, then jumped by 8525.0% to $345.0 million in 2025, then sank by 197.68% to -$337.0 million in 2026.
• The last three Gains from Investment Securities figures came in at -$337.0 million (Q1 2026), $345.0 million (Q4 2025), and -$134.0 million (Q3 2025), per Business Quant data.